Venrock's Results

Since 1969, Venrock has developed into one of this country's premier venture capital firms with offices in Palo Alto, New York, Cambridge and Israel.  Venrock continues the eight-decade Rockefeller tradition of funding entrepreneurs and establishing successful, enduring companies.  We have invested $2.5 billion in 442 companies over the past 41 years, resulting in 125 IPOs and 128 M&A exits. Venrock's returns place it among the top tier venture capital firms that have achieved consistently superior performance.

Venrock currently oversees 117 portfolio investments across the information technology, healthcare, and energy sectors and has been behind pioneers including Adify, Adnexus Therapeutics, Apple Computer, Centocor, Check Point Software, DoubleClick, Gilead Sciences, Idec Pharmaceuticals, Illumina, Intel, Ironwood, Millennium Pharmaceuticals, Sirna Therapeutics, StrataCom, and Vontu.